agilon health, inc. provided earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue of $6,350 million to $6,420 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.385 USD | -2.09% | +3.71% | -57.11% |
05-09 | Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating | MT |
05-07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.11% | 2.26B | |
-21.78% | 2.93B | |
-16.39% | 2.92B | |
+5.57% | 234M | |
-41.30% | 192M | |
-40.78% | 108M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Provides Earnings Guidance for the Year Ending December 31, 2024